• Shares in Zogenix plunge after FDA issues refuse-to-file letter for Fintepla as seizure treatment in Dravet syndrome FirstWord Pharma Wed, 16 Apr 2025 13:39:49 GMT
• rosen, a globally recognized law firm: june 11 deadline in zogenix, inc. in securities class action - zgnx ACCESS Newswire Tue, 08 Apr 2025 15:30:30 GMT
• zogenix sells opioid analgesic zohydro er to pernix therapeutics for up to $383.5 million FirstWord Pharma Fri, 28 Mar 2025 16:42:07 GMT
• investor network: zogenix, inc. to host earnings call ACCESS Newswire Wed, 19 Feb 2025 02:55:16 GMT
• olema oncology appoints shawnte m. mitchell, j.d. as chief legal officer and corporate secretary The Manila Times Tue, 18 Feb 2025 12:05:43 GMT
• lead plaintiff deadline alert: faruqi & faruqi, llp encourages investors who suffered losses exceeding $100,000 investing in zogen... ACCESS Newswire Wed, 29 Jan 2025 04:58:07 GMT
• lennox gastaut syndrome market expected to rise, 2034 | glaxosmithkline, meda pharmaceuticals, roche, lundbeck, greenwich bioscien... The Globe and Mail Tue, 07 Jan 2025 21:53:21 GMT
• cdkl5 deficiency disorder market revenue to expand significantly by 2034, states delveinsight report | marinus pharma, takeda, zog... The Globe and Mail Tue, 26 Nov 2024 08:00:00 GMT
• Needle-Free Drug Injection Systems Business Analysis Report GlobeNewswire Thu, 01 Aug 2024 07:00:00 GMT
• global needle-free drug delivery systems market 2024 analysis by top key players |valeritas inc, zogenix inc, bd The NRI News Wed, 31 Jul 2024 04:22:49 GMT
• ucb announces extension of tender offer to acquire zogenix, inc. UCB Thu, 25 Jul 2024 07:00:00 GMT
• fda approves zogenix's drug for rare childhood epilepsy Yahoo News Canada Tue, 23 Jul 2024 00:11:05 GMT
• needle free diabetes management market 2024 by keyplayers and vendors: zogenix, 3m, antares pharma inc., glide pharmaceu – knowcas... KnowCasino Thu, 04 Jul 2024 19:11:35 GMT
• long-acting injectable medications market size [2024-2034] -eli lilly, alkermes, johnson & johnson, zogenix, durect, map – knowcas... KnowCasino Thu, 04 Jul 2024 16:36:57 GMT
• zogenix to participate in the bofa securities 2021 healthcare conference Quantisnow Sun, 30 Jun 2024 06:53:35 GMT
• zogenix presents new data at virtual aan 2021 showing improved executive function in lennox-gastaut syndrome ... Quantisnow Sun, 30 Jun 2024 04:56:43 GMT
• zogenix to participate in the 10th annual svb leerink global healthcare conference Quantisnow Sun, 30 Jun 2024 04:55:13 GMT
• vip siblings and www.vipsibling.com, new resources to support brothers & sisters of those living with severe, rare ... Quantisnow Sun, 30 Jun 2024 04:39:37 GMT
• zogenix to participate in the raymond james institutional investors conference Quantisnow Sun, 30 Jun 2024 04:27:24 GMT
• zogenix launches global access program for fintepla® (fenfluramine) oral solution Quantisnow Sun, 30 Jun 2024 04:24:46 GMT
• tevard biosciences and zogenix announce collaboration to advance novel gene therapies for dravet syndrome and ... Quantisnow Sun, 30 Jun 2024 04:20:30 GMT
• zogenix, zohydro er face familiar post-approval hurdles Yahoo Movies UK Sat, 29 Jun 2024 03:55:51 GMT
• zogenix (zgnx) reports q2 loss, misses revenue estimates Yahoo Movies UK Fri, 21 Jun 2024 19:19:18 GMT
• dravet syndrome pipeline forecast 2024: fda approvals, therapies, and leading companies | gw pharma, zogenix ... Barchart Thu, 20 Jun 2024 14:28:00 GMT
• regel therapeutics appoints stephen j. farr as chief executive officer citybiz Thu, 20 Jun 2024 07:00:00 GMT
• lennox-gastaut syndrome drug market global report | gw pharmaceuticals plc, insys therapeutics inc, zogenix inc ... PrimePair Wed, 19 Jun 2024 16:56:57 GMT
• UCB bangs drum for epilepsy drug in videos about ‘sound of profound’ seizure reduction Fierce Pharma Wed, 19 Jun 2024 07:00:00 GMT
• biotech stock roundup: zgnx's acquisition news, regn, blue's updates & more Yahoo Lifestyle UK Thu, 13 Jun 2024 20:06:48 GMT
• zogenix's (nasdaq:zgnx) wonderful 400% share price increase shows how capitalism can build wealth Yahoo New Zealand News Wed, 29 May 2024 12:59:39 GMT
• dravet syndrome treatment market looks ready for takeoff: biocodex, epygenix therapeutics, zogenix Newstrail Fri, 24 May 2024 09:19:48 GMT
• zogenix (zgnx) reports q2 loss, tops revenue estimates Yahoo Lifestyle UK Thu, 16 May 2024 04:29:16 GMT
• zogenix (zgnx) reports q1 loss, tops revenue estimates Yahoo News UK Mon, 13 May 2024 13:14:23 GMT
• zogenix (zgnx) reports q2 loss, tops revenue estimates Yahoo Lifestyle UK Sun, 12 May 2024 12:12:17 GMT
• zogenix (zgnx) may report negative earnings: know the trend ahead of q4 release Yahoo New Zealand News Sat, 11 May 2024 23:55:42 GMT
• zogenix (zgnx) reports q2 loss, tops revenue estimates Yahoo Lifestyle UK Thu, 09 May 2024 14:54:16 GMT
• pain management therapie market size (revenue) | pfizer, astrazeneca, zogenix inc. Motions Online Wed, 08 May 2024 05:10:01 GMT
• aacr annual meeting 2018 - alnylam pharmaceuticals, zogenix The Pharma Letter Tue, 07 May 2024 08:44:09 GMT
• when will zogenix, inc. (nasdaq:zgnx) turn a profit? Yahoo Canada Shine On Mon, 06 May 2024 21:00:02 GMT
• zogenix (zgnx) reports q3 loss, tops revenue estimates Yahoo Movies Canada Fri, 03 May 2024 19:30:00 GMT
• cdkl5 deficiency disorder (cdd) industry research study |marinus pharmaceuticals, ovid therapeutics/takeda ... Motions Online Tue, 30 Apr 2024 17:20:11 GMT
• long-acting injectable medications market business insights, key trend analysis | eli lilly, alkermes, johnson & ... Amoré Tue, 30 Apr 2024 07:00:00 GMT
• zogenix, inc. (zgnx) soars: stock adds 18.6% in session Yahoo Canada Shine On Wed, 17 Apr 2024 13:30:59 GMT
• dravet syndrome treatment market data and in-depth analysis to 2030 | epygenix therapeutics, gw pharmaceuticals ... Currency News Centre Sun, 14 Apr 2024 22:35:53 GMT
• are options traders betting on a big move in zogenix (zgnx) stock? Yahoo Movies UK Thu, 04 Apr 2024 21:10:18 GMT
• ucb announces extension of tender offer to acquire zogenix, inc. UCB Sun, 24 Mar 2024 07:00:00 GMT
• long-acting injectable medications market business insights, key trend analysis | eli lilly, alkermes, johnson & ... Amoré Tue, 19 Mar 2024 15:15:13 GMT
• pain management therapie market 2024 [swot] analysis | pfizer, astrazeneca, zogenix inc., boston scientific ... Amoré Tue, 19 Mar 2024 14:06:59 GMT
• needle free diabetes management industry key trends |zogenix, 3m, antares pharma inc. Amoré Thu, 14 Mar 2024 09:01:00 GMT
• zogenix has $3.4b opportunity with pediatric epilepsy asset, bofa says in bullish initiation AOL Sun, 10 Mar 2024 16:57:52 GMT
• needle free drug delivery devices market growing massively by-injex pharma ag, antares pharma inc., zogenix inc ... Artrocker Tue, 30 Jan 2024 04:54:06 GMT
• ucb announces extension of tender offer to acquire zogenix, inc. UCB Wed, 03 Jan 2024 08:00:00 GMT
• long-acting injectable medications market research report 2023 -eli lilly, alkermes, johnson & johnson, zogenix ... Rough Cut Reviews Tue, 02 Jan 2024 06:20:26 GMT
• long-acting injectable medications market size & analysis by 2023 -2029 -eli lilly, alkermes, johnson & johnson ... Rough Cut Reviews Tue, 02 Jan 2024 05:13:01 GMT
• zogenix, inc. v. apotex inc. - fintepla® (fenfluramine hcl) | robins kaplan llp - jdsupra JD Supra Fri, 22 Dec 2023 08:00:00 GMT
• key u.s. district court cases with implications for ip in the new year IPWatchdog.com Thu, 14 Dec 2023 08:00:00 GMT
• needle-free injection device industry to set phenomenal growth from 2023 to 2029 |zogenix, inovio, glide pharma ... Artrocker Wed, 13 Dec 2023 11:45:04 GMT
• long-acting injectables market size and forecast -eli lilly, pfizer, glaxosmithkline, johnson & johnson, lupin ... Artrocker Tue, 05 Dec 2023 09:12:37 GMT
• long-acting injectable medications market size & analysis by 2023 -2029 -eli lilly, alkermes, johnson & johnson ... Artrocker Mon, 04 Dec 2023 12:48:05 GMT
• pediatric sport-related concussion: recommendations from the ... AAP Mon, 04 Dec 2023 08:10:08 GMT
• dravet syndrome treatment industry to witness huge growth by 2030 | gw pharmaceuticals, opko health, zogenix ... Argyle Report Fri, 01 Dec 2023 02:49:16 GMT
• photophobia drug industry opportunities – achelios, zogenix, biofrontera ag – salisburyandstonehenge salisburyandstonehenge Wed, 29 Nov 2023 08:20:12 GMT
• fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of dravet syndrome Wiley Online Library Tue, 28 Nov 2023 08:00:00 GMT
• ucb announces extension of tender offer to acquire zogenix, inc. UCB Mon, 23 Oct 2023 07:00:00 GMT
• fintepla[®▼] (fenfluramine) approved in japan for the treatment ... UCB Mon, 23 Oct 2023 07:00:00 GMT
• ucb now at the inflection point – ready to start a new phase of growth UCB Mon, 23 Oct 2023 07:00:00 GMT
• gsk v. teva's continued ripple effects | axinn, veltrop & harkrider llp - jdsupra JD Supra Wed, 11 Oct 2023 07:00:00 GMT
• new investigational drug offers relief for patients with treatment ... NYU Langone Health Mon, 09 Oct 2023 07:00:00 GMT
• Lennox-Gastaut Syndrome Market is Likely to Increase at a GlobeNewswire Thu, 05 Oct 2023 07:00:00 GMT
• zogenix announces proposed public offering of 4.3 mln shares Reuters Mon, 02 Oct 2023 07:00:00 GMT
• fintepla helps reduce seizures in dravet children in phase 3 trial... Dravet Syndrome News Tue, 19 Sep 2023 07:00:00 GMT
• ucb now at the inflection point – ready to start a new phase of growth UCB Thu, 27 Jul 2023 07:00:00 GMT
• axinn ip update: district of delaware magistrate judge recommends dismissal of claims of induced infringement in ... JD Supra Thu, 29 Jun 2023 07:00:00 GMT
• district of delaware magistrate judge recommends dismissal of ... Lexology Wed, 28 Jun 2023 07:00:00 GMT
• CDKL5 Deficiency Disorder Market to Witness Upsurge in Growth, Assesses DelveInsight | Key Companies in the Market - Jazz, Stoke, ... PR Newswire Tue, 06 Jun 2023 07:00:00 GMT
• fintepla (formerly zx008) for the treatment of dravet syndrome Dravet Syndrome News Fri, 21 Apr 2023 07:00:00 GMT
• ucb announces fintepla® (fenfluramine) oral solution is now ... PR Newswire Mon, 17 Apr 2023 07:00:00 GMT
• abortion ruling could undermine the f.d.a.'s drug-approval authority The New York Times Tue, 11 Apr 2023 07:00:00 GMT
• schizophrenia clinical trials pipeline analysis: 60+ companies are ... PR Newswire Wed, 05 Apr 2023 07:00:00 GMT
• dravet children's behavioral, emotional gains tied to fintepla |... Dravet Syndrome News Tue, 31 Jan 2023 08:00:00 GMT
• sun pharma to buy concert, pick up experimental hair loss drug BioPharma Dive Thu, 19 Jan 2023 08:00:00 GMT
• meeting highlights from the committee for medicinal products for ... European Medicines Agency | Fri, 16 Dec 2022 08:00:00 GMT
• ucb publishes results of fintepla for lennox-gastaut syndrome Labiotech.eu Thu, 24 Nov 2022 08:00:00 GMT
• ucb announces extension of tender offer to acquire zogenix, inc. UCB Wed, 09 Nov 2022 08:00:00 GMT
• ucb updates financial guidance for 2022 while maintaining 2025 financial guidance UCB Wed, 09 Nov 2022 08:00:00 GMT
• ucb announces extension of tender offer to acquire zogenix, inc. UCB Tue, 01 Nov 2022 07:00:00 GMT
• you're cured till you're not: should disease-free survival be used ... ASCO Journals Mon, 31 Oct 2022 07:00:00 GMT
• ucb pens multiple collabs to boost awareness, understanding about seizure clusters FiercePharma Mon, 22 Aug 2022 07:00:00 GMT
• lowering fintepla doses with age or diacomit can be effective: study Dravet Syndrome News Tue, 09 Aug 2022 07:00:00 GMT
• lower fintepla doses with age or diacomet can be effective for... Dravet Syndrome News Tue, 09 Aug 2022 07:00:00 GMT
• fda preemption: implications of dobbs decision for uniform access ... Manatt, Phelps & Phillips, LLP Mon, 08 Aug 2022 07:00:00 GMT
• strong first six months – ucb with continued delivery and strong resilience UCB - Inspired by patients. Driven by science. Thu, 28 Jul 2022 07:00:00 GMT
• no signs of heart problems over 3 years with fintepla in children Dravet Syndrome News Tue, 26 Jul 2022 07:00:00 GMT
• needle-free injection system market overall study report 2022-2028 | antares pharma, inc., endo international plc ... Digital Journal Tue, 19 Jul 2022 07:00:00 GMT
• ucb updates financial guidance for 2022 while maintaining 2025 financial guidance UCB Fri, 24 Jun 2022 07:00:00 GMT
• fenfluramine seems effective for lennox-gastaut syndrome Medical Xpress Mon, 02 May 2022 07:00:00 GMT
• UCB wins wider Fintepla label, setting up showdown with Jazz's Epidiolex Fierce Pharma Mon, 28 Mar 2022 07:00:00 GMT
• FINTEPLA® (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS) PR Newswire Mon, 28 Mar 2022 07:00:00 GMT
Zogenix, Inc(NASDAQ:ZGNX) 
Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials...
Website: http://www.zogenix.com
Full Time Employees: 218 (May 2021)
Sector: Healthcare
Industry: Biotechnology